Press Releases

VistaGen Therapeutics to Present at Biotech Showcase™ 2017

Jan 5, 2017

VistaGen Therapeutics Grants Exclusive Sublicense of Cardiac Stem Cell Technologies to BlueRock Therapeutics

Dec 14, 2016

VistaGen Therapeutics to Present at 9th Annual LD Micro Main Event

Nov 30, 2016

VistaGen Therapeutics Reports Second Quarter 2017 Financial Results and Business Update

Nov 14, 2016

VistaGen Therapeutics Appoints Mark A. McPartland Vice President of Corporate Development and Investor Relations

Oct 4, 2016

VistaGen Therapeutics Provides Business Outlook and Sets Corporate Milestones

Sep 22, 2016

VistaGen Therapeutics Appoints Pharmaceutical CNS Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer

Jun 20, 2016

VistaGen Completes $10 Million Public Offering

May 16, 2016

VistaGen Announces Nasdaq Listing and Pricing of $10.0 Million Public Offering

May 10, 2016

VistaGen Therapeutics Appoints Jerry Gin, Ph.D., MBA to its Board of Directors

Mar 30, 2016